全文获取类型
收费全文 | 2706篇 |
免费 | 183篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 116篇 |
妇产科学 | 66篇 |
基础医学 | 197篇 |
口腔科学 | 242篇 |
临床医学 | 319篇 |
内科学 | 641篇 |
皮肤病学 | 11篇 |
神经病学 | 260篇 |
特种医学 | 86篇 |
外科学 | 312篇 |
综合类 | 83篇 |
一般理论 | 1篇 |
预防医学 | 194篇 |
眼科学 | 52篇 |
药学 | 216篇 |
中国医学 | 2篇 |
肿瘤学 | 93篇 |
出版年
2021年 | 40篇 |
2020年 | 26篇 |
2019年 | 53篇 |
2018年 | 44篇 |
2017年 | 43篇 |
2016年 | 36篇 |
2015年 | 46篇 |
2014年 | 69篇 |
2013年 | 74篇 |
2012年 | 138篇 |
2011年 | 134篇 |
2010年 | 90篇 |
2009年 | 60篇 |
2008年 | 92篇 |
2007年 | 98篇 |
2006年 | 110篇 |
2005年 | 107篇 |
2004年 | 73篇 |
2003年 | 96篇 |
2002年 | 72篇 |
2001年 | 80篇 |
2000年 | 87篇 |
1999年 | 81篇 |
1998年 | 29篇 |
1997年 | 25篇 |
1996年 | 22篇 |
1994年 | 24篇 |
1993年 | 24篇 |
1992年 | 50篇 |
1991年 | 61篇 |
1990年 | 61篇 |
1989年 | 58篇 |
1988年 | 52篇 |
1987年 | 62篇 |
1986年 | 59篇 |
1985年 | 60篇 |
1984年 | 32篇 |
1983年 | 44篇 |
1982年 | 35篇 |
1980年 | 35篇 |
1979年 | 46篇 |
1978年 | 44篇 |
1976年 | 20篇 |
1975年 | 21篇 |
1974年 | 31篇 |
1973年 | 26篇 |
1972年 | 37篇 |
1971年 | 22篇 |
1970年 | 24篇 |
1969年 | 23篇 |
排序方式: 共有2896条查询结果,搜索用时 31 毫秒
1.
Jacey Nishiguchi Anusha McNamara Colleen S. Surlyn Kellene Vokaty Eagen Laura Feeney Vivian Lian David E. Smith 《Journal of viral hepatitis》2022,29(1):21-25
In 2016, an eConsult service was developed within a safety net health system to expand access to hepatitis C (HCV) treatment in the primary care setting. The eConsult system provides individualized treatment recommendations from specially trained primary care pharmacists and primary care physicians to primary care providers with less experience in the rapidly changing treatment of HCV. Since its launch, this service has had a large impact in expanding care to a largely homeless and low-income urban population within our health system. We now aim to evaluate its efficacy in curing HCV. In this retrospective cohort study, we describe rates of sustained virologic response 12 weeks after treatment completion (SVR12) for those who received primary care-based HCV treatment through the eConsult system with those who were treated in primary care independent of an eConsult from 2017 to 2019. We found there was no significant difference in the proportion of patients who achieved SVR12 between the two groups. Overall, >90% of patients who received treatment achieved SVR12. Approximately 40% of patients treated for HCV received an eConsult, suggesting utility of the eConsult in expanding access and coordinating treatment for patients within our network. 相似文献
2.
We report four years of observational data from a large UK hospital and tertiary referral unit, following the introduction of a rotational thromboelastometry-guided algorithm for treatment of coagulopathy in major obstetric haemorrhage. Fibrinogen concentrate was used to treat acquired hypofibrinogenaemia as defined by a FibTEM A5 value of < 7 mm, or 7–12 mm with ongoing or high risk of haemorrhage. Of 32,647 deliveries over 4 years, 893 (2.7%) women had an estimated blood loss ≥ 1500 ml. Two-hundred and three (23%) of these had a FibTEM A5 ≤ 12 mm and 110 received fibrinogen concentrate. We compared clinical outcomes and blood product use with 52 patients who met the same criteria, over a 12-month pre-intervention period during which shock packs were used. In the algorithm group, there was a significant reduction in the number of units (p < 0.0001) and total volume (p = 0.0007) of blood products transfused, with a reduction in transfusion-associated circulatory overload (p = 0.002). Women with placental abruption exhibited more severe coagulopathy and required higher doses of fibrinogen concentrate than women who bled due to other causes. Analysis of rotational thromboelastometry results demonstrated that coagulopathy is not observed in all women who suffer obstetric haemorrhage and cannot be predicted solely by blood loss. Therefore, formulaic treatment with blood products is not justified. When coagulopathy does occur, it appears to be multifactorial and can be severe. Point-of-care testing allows early identification and individualised treatment of coagulopathy. This is supported by the improved outcomes reported. 相似文献
3.
4.
5.
6.
7.
Systemic mastocytosis (SM) is a myeloproliferative disorder, characterized by a clonal proliferation of abnormal mast cells accumulating in internal organs and sometimes in the skin, leading to cutaneous and systemic symptoms. Mutations within the gene KIT, which encodes the receptor tyrosine kinase (KIT) on mast cells, is found in most patients with SM. We report a case of a 62‐year‐old woman presenting with a pruritic rash on her limbs and trunk. Several years later she developed gastrointestinal symptoms, associated with raised serum tryptase. Skin and bone marrow biopsies confirmed a diagnosis of SM, initially presenting with urticaria pigmentosa. Responses to multiple therapies, including potent topical steroids, oral antihistamines, phototherapy and the tyrosine kinase inhibitor, nilotinib, were inadequate. Treatment with cladribine (2‐chlorodeoxyadenosine) produced a marked and sustained reduction in her symptoms and serum tryptase level. 相似文献
8.
9.
10.